LIDDS Competitors and Similar CompaniesClear all
Shanghai Junshi Biosciences's competitors and similar companies include Kyowa Kirin.
 Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 2012 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Shanghai, CN HQ | |
Employees | Employees 2,578 | Employees 5,669 |
Financial | ||
Revenue (est.) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods ¥466.5m (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit ¥2b (FY, 2025) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income (¥1b) (FY, 2025) | Net income ¥67b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company